10g
Showing 4601–4637 of 4637 results
-
VEGF120, Mouse
VEGF was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was subsequently found to be identical to an independently discovered vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based on its ability to increase the permeability of capillary blood vessels. Three mouse cDNA clones, which arise through alternative splicing and which encode mature mouse monomeric VEGF having 120, 164, or 188, amino acids, respectively, have been identified. Two receptor tyrosine kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR), both members of the type III subclass of RTKs containing seven immunoglobulin-like repeats in their extracellular domains, have been shown to bind VEGF with high affinity. The roles of the homodimers of KDR, Flt, and the heterodimer ofKDR/Flt in VEGF signal transduction remain to be elucidated.In vivo, VEGF has been found to be a potent angiogenesis inducer.
-
VEGF121, Human
VEGF-A121 is one of five isoforms (121, 145, 165, 189, and 206) of VEGF protein, a cytokine belonging to the Platelet Differentiation Growth Factor (PDGF) family, and existing as a disulfide-linked homodimeric glycoprotein. In contrast to the longer isoforms, VEGF-A121 is more freely diffusible, and cannot bind to heparin. In vivo, VEGF is expressed predominantly in lung, heart, kidney, and adrenal glands, and the expression of VEGF is up-regulated by a number of growth factors, including PDGF, Fibroblast Growth Factor (FGF), Epidermal Growth Factor (EGF), and Tumor Necrosis Factor (TNF). VEGF signals via binding to two tyrosine kinase receptors: the Fms-like tyrosine kinase 1 (Flt-1) and the kinase domain receptor (KDR). VEGF is a specific mitogen and survival factor, contributing to abnormal angiogenesis and cancer development.
-
VEGF164, Mouse
Vascular Endothelial Growth Factor (VEGF) was initially purified from media conditioned by normal bovine pituitary folliculo-stellate cells and by a variety of transformed cell lines as a mitogen specific for vascular endothelial cells. It was subsequently found to be identical to an independently discovered vascular permeability factor (VPF), which was previously identified in media conditioned by tumor cell lines based on its ability to increase the permeability of capillary blood vessels. Three mouse cDNA clones, which arise through alternative splicing and which encode mature mouse monomeric VEGF having 120, 164, or 188, amino acids, respectively, have been identified. Two receptor tyrosine kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR), both members of the type III subclass of RTKs containing seven immunoglobulin-like repeats in their extracellular domains, have been shown to bind VEGF with high affinity. The roles of the homodimers of KDR, Flt, and the heterodimer of KDR/Flt in VEGF signal transduction remain to be elucidated. In vivo, VEGF has been found to be a potent angiogenesis inducer.
-
VEGF164, Rat (CHO-expressed)
Vascular Endothelial Growth Factor A164 (VEGF-A164), a member of the cysteine knot growth factor, is one of major isoforms of VEGF-As. VEGF-As are endothelial cell-specific mitogens with angiogenic and vascular permeability-inducing properties. During maturation, rat VEGF-A is alternatively spliced to generate rVEGF-A120, rVEGF-A164 and rVEGF-A188 which correspond to hVEGF-A121, hVEGF-A165 and hVEGF-A189 in human, respectively (the numbers designate the amino acid residues). The active form of rVEGF-A164 is either a homodimeric or heterodimeric polypeptides which bind to the transmembrane tyrosine kinases receptors FLT1, FLK1 or KDR or to the non-tyrosine kinase neuropilin receptors NRP1/2.
-
VEGF165, Human
Vascular Endothelial Growth Factor (VEGF) is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, Vascular Endothelial Growth Factor (VEGF) plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates Vascular Endothelial Growth Factor (VEGF) in the induction of tumor metastasis and intra-ocular neovascular syndromes. Vascular Endothelial Growth Factor (VEGF) signals through the three receptors; fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product.
-
VEGF165, Human(HEK 293-expressed)
Vascular Endothelial Growth Factor (VEGF) is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, Vascular Endothelial Growth Factor (VEGF) plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates Vascular Endothelial Growth Factor (VEGF) in the induction of tumor metastasis and intra-ocular neovascular syndromes. Vascular Endothelial Growth Factor (VEGF) signals through the three receptors; fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product.
-
Veratrole
Molecular Formula : C8 H10 O2
-
Vincamine
Molecular Formula : C21 H26 N2 O3
-
Vinylbenzyl Chloride, Mixture of 2, 3- and 4-isomers (Stabilized with TBC)
Molecular Formula : 2 C9 H9 Cl
-
Vinylphosphonic Acid
Molecular Formula : C2H5O3P
-
Vitamin A Acetate
Molecular Formula : C22 H32 O2
-
Vitamin D2 O-t-Butyldimethylsilyl Ether
Molecular Formula : C34H58OSi
-
Vitamin K4
Molecular Formula : C15 H14 O4
-
Wright’s Stain, Certified, Powder
Wright’s Stain, Certified, Powder
-
Xanthine
Molecular Formula : C5 H4 N4 O2
-
Xanthone
Molecular Formula : C13 H8 O2
-
Xylan
Molecular Formula : C5H10O6
-
Xylene Cyanol FF (Technical Grade)
Molecular Formula : C25H27N2NaO6S2
-
Xylenesulfonic Acid Sodium Salt
Molecular Formula : C8H9NaO3S
-
Ytterbium Chloride, Hexahydrate
Ytterbium Chloride, Hexahydrate
-
Z-L-Arginine
Molecular Formula : C14H20N4O4
-
Z-L-Phenylglycine
Molecular Formula : C6 H6 F N O . H Cl
-
Zephirol
Molecular Formula : C21 H38 N . Cl
-
Zinc 2-Mercaptobenzothiazole
Molecular Formula : C14H8N2S4Zn
-
Zinc Acetate
Molecular Formula : C4H6O4Zn
-
Zinc Acetate Dihydrate
Molecular Formula : 2 C2 H3 O2 . Zn . 2 H2 O
-
Zinc Chloride Hydrate
Molecular Formula : ZnCl2 .xH2O
-
Zinc Difluoride
Molecular Formula : F2Zn
-
Zinc Dimethyldithiocarbamate
Molecular Formula : C6 H12 N2 S4 Zn
-
Zinc Oxide
Molecular Formula : ZnO
-
Zinc Pyrithione, 48 Percent Aqueous Suspension
Zinc Pyrithione, 48 Percent Aqueous Suspension
-
Zinc Sulfate Monohydrate
Molecular Formula : H2O4S . Zn . H2O
-
Zinc-Copper Couple
Molecular Formula : CuZn
-
Zolpidem Acid
Molecular Formula : C17 H16 N2 O2
-
β-Benzyl L-Aspartic Acid N-carboxyanhydride
Molecular Formula : C12 H11 N O5
-
γ-Aminobutyric Acid
Molecular Formula : C4 H9 N O2
-
ψ-Tropine
Molecular Formula : C8 H15 N O